Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.72 USD | +2.38% | -1.65% | -7.99% |
04-30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
04-30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.99% | 1.69B | |
+34.35% | 705B | |
+29.39% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
-3.03% | 210B | |
+10.02% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Cantor Fitzgerald Adjusts Price Target on Harmony Biosciences Holdings to $75 From $71, Maintains Overweight Rating